Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

CT scans can find serious prostate cancer even when PSA levels are low.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Possible link between androgens and COVID-19 severity; more research needed.

Certain hormone treatments can improve acne and related conditions in women.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.